| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Phase II Study of sEphB4-HSA in Metastatic Castration-Resistant Prostate Cancer
|
VanderWeele, David J.
|
|
|
20 |
6 |
p. 575-580
|
article
|
| 2 |
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma
|
Talukder, Rafee
|
|
|
20 |
6 |
p. 558-567
|
article
|
| 3 |
BCG Administration after Prior Radiation Treatment for Prostate Cancer
|
Durant, Adri M.
|
|
|
20 |
6 |
p. 591-597
|
article
|
| 4 |
Calibrated Regression Models Based on the Risk of Clinical Nodal Metastasis Should be Used as Decision Aids for Prostate Cancer Staging to Reduce Unnecessary Imaging
|
Hayes, Mitchell
|
|
|
20 |
6 |
p. e490-e497
|
article
|
| 5 |
Clinical and Patient-Reported Outcomes of Advanced Urothelial Carcinoma Following Discontinuation of PD-1/L1 Inhibitor Therapy
|
Morgans, Alicia K
|
|
|
20 |
6 |
p. 543-552
|
article
|
| 6 |
Clinical Factors Associated With Pathological Grade Group 1 Patients in D'Amico Intermediate-Risk Group Following Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group)
|
Sugino, Yusuke
|
|
|
20 |
6 |
p. 593-600
|
article
|
| 7 |
Clinical Risk Factors Associated With Small Renal Mass Malignant Histology in a Multi-Ethnic Population Undergoing Partial Nephrectomy
|
Zhu, Denzel
|
|
|
20 |
6 |
p. e465-e472
|
article
|
| 8 |
Complete response in Patients With Lung-Only Metastatic Prostate Cancer: Outcome Analysis
|
Kase, Adam M.
|
|
|
20 |
6 |
p. e485-e489
|
article
|
| 9 |
Continuous IV Infusion of 5-Flourouracil in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer
|
Manogue, Charlotte
|
|
|
20 |
6 |
p. 586-590
|
article
|
| 10 |
Decreased Muscle Mass Prior to and Following Chemotherapy Predicts Morbidity in Testicular Cancer Patients Undergoing Post-Chemotherapy Retroperitoneal Lymph Node Dissection
|
Baky, FadyJ
|
|
|
20 |
6 |
p. e460-e464
|
article
|
| 11 |
Editorial Board
|
|
|
|
20 |
6 |
p. A1
|
article
|
| 12 |
Evaluation of Provider Preferences in First-Line Metastatic Renal Cell Carcinoma: Comparison Between Dual Immunotherapy vs. Immunotherapy/Tyrosine Kinase Inhibitors
|
Chablani, Priyanka V.
|
|
|
20 |
6 |
p. 510-514
|
article
|
| 13 |
Focal High-Intensity Focused Ultrasound vs. Active Surveillance for ISUP Grade 1 Prostate Cancer: Medium-Term Results of a Matched-Pair Comparison
|
Marra, Giancarlo
|
|
|
20 |
6 |
p. 592-604
|
article
|
| 14 |
Incidence of Germline Variants in Familial Bladder Cancer and Among Patients With Cancer Predisposition Syndromes
|
Mossanen, Matthew
|
|
|
20 |
6 |
p. 568-574
|
article
|
| 15 |
Intravesical Therapy Compared to Radical Cystectomy Among Patients With Non-Muscle Invasive Bladder Cancer Requiring Additional Treatment After Induction BCG
|
Anderson, Christopher B.
|
|
|
20 |
6 |
p. 595-603
|
article
|
| 16 |
Low-Dose Enzalutamide in Metastatic Prostate Cancer—Longevity Over Conventional Survival Analysis
|
Vinh-Hung, Vincent
|
|
|
20 |
6 |
p. e473-e484
|
article
|
| 17 |
Management and Health Resource Use of Patients With Metastatic Renal Cell Carcinoma treated With Systemic Therapy Over 2014-2017 in France: A National Real-World Study
|
Escudier, Bernard
|
|
|
20 |
6 |
p. 533-542
|
article
|
| 18 |
Partial Versus Radical Nephrectomy: Complexity of Decision-Making and Utility of AUA Guidelines
|
Campbell, Rebecca A.
|
|
|
20 |
6 |
p. 501-509
|
article
|
| 19 |
Percutaneous Microwave Ablation is Comparable to Cryoablation for the Treatment of T1a Renal Masses: Results From a Cross-Sectional Study
|
Lucignani, Gianpaolo
|
|
|
20 |
6 |
p. e506-e511
|
article
|
| 20 |
Risk-Based Assessment Of the Impact Of Intravesical Therapy on Recurrence-Free Survival Rate Following Resection of Suspected Low-grade, Non-muscle-invasive Bladder Cancer (NMIBC): A Southwest Oncology Groups (SWOG) S0337 Posthoc Analysis
|
Corsi, Nicholas J.
|
|
|
20 |
6 |
p. e498-e505
|
article
|
| 21 |
Table of contents
|
|
|
|
20 |
6 |
p. A3-A7
|
article
|
| 22 |
Temporal Characteristics of Adverse Events of Tivozanib and Sorafenib in Previously Treated Kidney Cancer
|
Zengin, Zeynep B.
|
|
|
20 |
6 |
p. 553-557
|
article
|
| 23 |
The Clinical Significance of Maximum Tumor Diameter on MRI in Men Undergoing Radical Prostatectomy or Definitive Radiotherapy for Locoregional Prostate Cancer
|
Hutten, Ryan
|
|
|
20 |
6 |
p. e453-e459
|
article
|
| 24 |
The Prognostic Significance of Homologous Recombination Repair Pathway Alterations in Metastatic Hormone Sensitive Prostate Cancer
|
Lee, Aaron M.
|
|
|
20 |
6 |
p. 515-523
|
article
|
| 25 |
Treatment Intensification Patterns and Utilization in Patients with Metastatic Castration-Sensitive Prostate Cancer
|
Heath, Elisabeth I.
|
|
|
20 |
6 |
p. 524-532
|
article
|
| 26 |
Treatment of Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review of Economic Evaluations
|
Pelloux-Prayer, Rémi
|
|
|
20 |
6 |
p. 594-602
|
article
|
| 27 |
Two Clinical Cases of Li-Fraumeni Syndrome and Prostate Cancer: Genetic Counseling and Clinical-Surgical Management
|
Abad-Carratalà, Guillem
|
|
|
20 |
6 |
p. 581-585
|
article
|
Journal description